Company / Gross Margin
BIOMERICA INC Gross Margin History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Margin
9.4%
FY2024
5-year range
8.3% / 15.8%
FY2020-FY2024
Trend
-16.8%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Gross Margin has fluctuated over the past 9 years, ranging from 5.1% in FY2020 to 34.9% in FY2016.
Based on SEC 10-K filings.
9.4% in FY2024 with a 5-year CAGR of -15.5%.
Improved from 8.3% to 9.4% over the past 2 years.
Gross Margin over time
Growth rates
- 3-Year Change
- -6.4pp
- 5-Year Change
- -15.5pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2024, gross margin decreased 16.8% year-over-year.
- Peak gross margin was recorded in FY2016.
- Lowest gross margin in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -6.26 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | 9.4% | -16.8% |
| FY2023 | 11.3% | +35.1% |
| FY2022 | 8.3% | -47.1% |
| FY2021 | 15.8% | +210.0% |
| FY2020 | 5.1% | -79.5% |
| FY2019 | 24.8% | +0.0% |
| FY2018 | 24.8% | -21.2% |
| FY2017 | 31.5% | -9.7% |
| FY2016 | 34.9% | +17.7% |
As of FY2024 · SEC Form 10-K · Last checked Jun 22, 2026